Clinical trial

S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell…

NCT00053014 · SWOG Cancer Research Network, Other · Terminated

Key facts

NCT number NCT00053014
Title S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
Official title S0125, A Phase II Study Of Chimerism-Mediated Immunotherapy (CMI) Using Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation In Older Patients With Acute Myeloid Leukemia (AML) In First Complete Remission (A BMT Study)
Lead sponsor SWOG Cancer Research Network, Other
Collaborators National Cancer Institute (NCI) NIH
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Leukemia
Intervention type Biological, Drug, Procedure, Radiation
Interventions therapeutic allogeneic lymphocytes, cyclosporine, fludarabine, mycophenolate mofetil, peripheral blood stem cell transplantation, radiation therapy
Enrollment 5
Start date Apr 1, 2003
Primary completion Jun 1, 2005
Completion Jun 1, 2006
First posted Jan 28, 2003
Last update posted Mar 25, 2015
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies